AU2001296151A1 - 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases - Google Patents

7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases

Info

Publication number
AU2001296151A1
AU2001296151A1 AU2001296151A AU9615101A AU2001296151A1 AU 2001296151 A1 AU2001296151 A1 AU 2001296151A1 AU 2001296151 A AU2001296151 A AU 2001296151A AU 9615101 A AU9615101 A AU 9615101A AU 2001296151 A1 AU2001296151 A1 AU 2001296151A1
Authority
AU
Australia
Prior art keywords
diseases
treatment
chemokine
psoriasis
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296151A
Inventor
Roger Bonnert
Iain Walters
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001296151A1 publication Critical patent/AU2001296151A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/06—Heterocyclic compounds containing pteridine ring systems with a nitrogen atom directly attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

Pteridine compounds of formula (I) processes and intermediates used in their preparation, pharmaceutical compositions containing them and their use in the treatment of inflammatory diseases such as psoriasis, rheumatoid arthritis, diseases in which angiogenesis is assocated with raised CXCR2 chemokine levels (diabetic retinopathy) and COPD. The compounds are ligands for chemokine receptors and medical indications mentioned in the description include: diseases of the respiratory tract (COPDD, asthma, bronchitis, rhinitis, fibroid lung, pneumonia, etc.), diseases of the bones and joints (arthritis, etc.), skin-diseases (psoriasis, etc), diseases of the gastrointestinal tract, diseases in other tissues and systemic disease (multipe sclerosis, atherosclerosis, AIDS, type 1 diabetes, leprosy, sepsis, etc.), allograft rejection, cancers, cystic fibrosis, stroke, burn wounds, skin ulcers, reproductive disease and more.
AU2001296151A 2000-10-20 2001-10-16 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases Abandoned AU2001296151A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0003828 2000-10-20
SE0003828A SE0003828D0 (en) 2000-10-20 2000-10-20 Novel compounds
PCT/SE2001/002265 WO2002032507A1 (en) 2000-10-20 2001-10-16 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases

Publications (1)

Publication Number Publication Date
AU2001296151A1 true AU2001296151A1 (en) 2002-04-29

Family

ID=20281519

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296151A Abandoned AU2001296151A1 (en) 2000-10-20 2001-10-16 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases

Country Status (9)

Country Link
US (1) US7071193B2 (en)
EP (1) EP1328319B1 (en)
JP (1) JP4250416B2 (en)
AT (1) ATE350102T1 (en)
AU (1) AU2001296151A1 (en)
DE (1) DE60125801T2 (en)
ES (1) ES2276836T3 (en)
SE (1) SE0003828D0 (en)
WO (1) WO2002032507A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2413324A (en) * 2004-04-22 2005-10-26 4 Aza Bioscience Nv Pharmaceutically active pteridine derivatives
US7276506B2 (en) * 1998-12-28 2007-10-02 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
US6946465B2 (en) * 1999-02-02 2005-09-20 4 Aza Bioscience Nv Immunosuppressive effects of pteridine derivatives
SE9903544D0 (en) * 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
GB2359551A (en) * 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
SE0102716D0 (en) * 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221829D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221828D0 (en) * 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
EP1658081B1 (en) * 2003-08-29 2007-10-24 4 Aza Ip Nv Immunosuppressive effects of pteridine derivatives
WO2005025574A2 (en) * 2003-09-12 2005-03-24 4 Aza Bioscience Nv PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES.
EP1673092B1 (en) * 2003-10-17 2007-08-15 4 Aza Ip Nv Heterocycle-substituted pteridine derivatives and their use in therapy
US20070032477A1 (en) * 2003-10-17 2007-02-08 Waer Mark J A Pteridine derivatives useful for making pharmaceutical compositions
GB0328243D0 (en) * 2003-12-05 2004-01-07 Astrazeneca Ab Methods
WO2008009079A2 (en) 2006-07-20 2008-01-24 Gilead Sciences, Inc. Substituted pteridines useful for the treatment and prevention of viral infections
US20170275287A1 (en) * 2014-08-22 2017-09-28 Janus Biotherapeutics, Inc. Novel n2, n4, n7, 6-tetrasubstituted pteridine-2,4,7-triamine and 2, 4, 6, 7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
US9670205B2 (en) 2015-03-04 2017-06-06 Gilead Sciences, Inc. Toll like receptor modulator compounds
WO2018045144A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. Toll like receptor modulator compounds
WO2018045150A1 (en) 2016-09-02 2018-03-08 Gilead Sciences, Inc. 4,6-diamino-pyrido[3,2-d]pyrimidine derivaties as toll like receptor modulators
TW202210480A (en) 2019-04-17 2022-03-16 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TWI751517B (en) 2019-04-17 2022-01-01 美商基利科學股份有限公司 Solid forms of a toll-like receptor modulator
TW202115056A (en) 2019-06-28 2021-04-16 美商基利科學股份有限公司 Processes for preparing toll-like receptor modulator compounds

Family Cites Families (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2924472A (en) 1957-06-27 1960-02-09 Gen Motors Corp Pipe joint seal
US3182062A (en) * 1962-02-28 1965-05-04 Smith Kline French Lab Synthesis of quinoxalines and analogues thereof
GB1009477A (en) 1962-02-13 1965-11-10 Smith Kline French Lab Novel process for preparing heterocyclic compounds
US3318900A (en) 1964-05-06 1967-05-09 Janssen Pharmaceutica Nv Derivatives of benzimidazolinyl piperidine
BE668603A (en) 1964-08-20
DE2331223C2 (en) 1972-06-19 1984-11-22 Kohjin Co., Ltd., Tokio / Tokyo S-substituted-2-thioadenosines, their 5'-monophosphates, processes for their preparation and pharmaceuticals containing them
JPS5188994A (en) 1975-02-04 1976-08-04 Shinkijichikan 88 aminoadeninjudotainoseizoho
US4120521A (en) 1975-08-28 1978-10-17 Rieber & Son Plastic-Industri A/S Combined mould element and sealing ring
EG12406A (en) 1976-08-12 1979-03-31 Janssen Pharmaceutica Nv Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
GB1600293A (en) 1977-02-04 1981-10-14 British Oceanics Ltd Sealing arrangements
US4188040A (en) 1977-04-06 1980-02-12 Firma WOCO Franz-Josef Wolf & Co. Sealing ring
DE2726959A1 (en) 1977-06-15 1979-01-18 Arlt Christian SEALING INSERT FOR SEALING TWO TUBES
FR2421899A1 (en) 1978-01-16 1979-11-02 Roussel Uclaf NEW TETRAHYDROPYRIDINYL-INDOLE DERIVATIVES AND THEIR SALTS, THE PREPARATION PROCESS AND THE MEDICINAL APPLICATION OF THESE NEW PRODUCTS
US4410528A (en) 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
DE3219522A1 (en) 1981-10-28 1983-12-01 Denso-Chemie Wedekind Kg, 5090 Leverkusen CONNECTOR SEAL FOR PIPES
FR2547888B1 (en) 1983-06-22 1985-12-13 Sabla Sa IMPLANT SEALING RING FOR INTERLOCKING PIPES
CA1338012C (en) 1987-04-27 1996-01-30 John Michael Mccall Pharmaceutically active amines
SE8800348L (en) 1988-02-03 1989-08-04 Forsheda Ab SEALING RING AND TOOLS FOR PRODUCING THEREOF
FR2659656B1 (en) 1990-03-15 1994-09-09 Sanofi Sa PYRIMIDINEDIONE-2,4 DERIVATIVES AND MEDICINAL PRODUCTS CONTAINING THEM.
DE4119767A1 (en) 1991-06-15 1992-12-17 Dresden Arzneimittel Prepn. of (pyrimid-2-yl-thio- or seleno-) acetic acid derivs. - by reacting the corresp. chloro:alkanoyl-amino cpd. with a rhodanide and water or an alcohol
US5169161A (en) 1991-09-19 1992-12-08 Hail Mary Rubber Co., Inc. Symmetrical gasket for pipe joints
DE4134089C2 (en) 1991-10-15 1994-10-13 Dueker Eisenwerk Thrust-proof sleeve connection
DE4229609C2 (en) 1992-09-04 2003-05-08 Forsheda Stefa Gmbh Sealing between two interlocking parts
US5521197A (en) 1994-12-01 1996-05-28 Eli Lilly And Company 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists
ES2200039T3 (en) 1995-12-08 2004-03-01 Pfizer Inc. HETEROCICLIC DERIVATIVES REPLACED AS CRF ANTAGONISTS.
GB9624482D0 (en) 1995-12-18 1997-01-15 Zeneca Phaema S A Chemical compounds
SE515033C2 (en) 1995-12-27 2001-06-05 Forsheda Ab sealing device
AU719434B2 (en) 1996-02-13 2000-05-11 Astrazeneca Ab Quinazoline derivatives as VEGF inhibitors
CA2244897C (en) 1996-03-05 2006-04-11 Zeneca Limited 4-anilinoquinazoline derivatives
AU2388697A (en) 1996-04-19 1997-11-12 Neurosearch A/S 1-(4-piperidyl)-benzimidazoles having neurotrophic activity
SK23399A3 (en) 1996-08-28 2000-08-14 Pfizer 6,5-hetero-bicyclic derivatives, use thereof and pharmaceutical composition on their base
GB9718972D0 (en) 1996-09-25 1997-11-12 Zeneca Ltd Chemical compounds
CN1064533C (en) * 1996-10-24 2001-04-18 沈春楼 Compound capsule for treating red swollen and heat-evil due to wind-cold-dampness
WO1998025617A1 (en) 1996-12-13 1998-06-18 Merck & Co., Inc. Substituted aryl piperazines as modulators of chemokine receptor activity
GB9714249D0 (en) 1997-07-08 1997-09-10 Angiogene Pharm Ltd Vascular damaging agents
AU8576098A (en) 1997-07-25 1999-02-16 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity
AR013669A1 (en) 1997-10-07 2001-01-10 Smithkline Beecham Corp COMPOUNDS AND METHODS
EP1035123B1 (en) 1997-11-28 2003-08-20 Sumitomo Pharmaceuticals Company, Limited Novel heterocyclic compounds
EA200000683A1 (en) 1998-01-19 2000-12-25 Пфайзер Инк. DERIVATIVES OF THE 4- (2-KETO-1-BENZIMIDAZOLINIL) PIPERIDINE AS AN ORL1 RECEPTOR AGONISTS
KR20010042001A (en) 1998-03-19 2001-05-25 무라타 도시카즈 Arylpiperidine derivatives and use thereof
WO1999051608A1 (en) 1998-04-03 1999-10-14 Du Pont Pharmaceuticals Company THIAZOLO[4,5-d]PYRIMIDINES AND PYRIDINES AS CORTICOTROPIN RELEASING FACTOR (CRF) ANTAGONISTS
MA26659A1 (en) 1998-08-06 2004-12-20 Pfizer NOVEL BENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESS FOR THEIR PREPARATION.
SE9802729D0 (en) 1998-08-13 1998-08-13 Astra Pharma Prod Novel Compounds
US5988695A (en) 1998-08-26 1999-11-23 S&B Technical Products, Inc. Pipe gasket with embedded ring
PE20001420A1 (en) 1998-12-23 2000-12-18 Pfizer CCR5 MODULATORS
WO2000039129A1 (en) 1998-12-28 2000-07-06 K.U. Leuven Research & Development Immunosuppressive effects of pteridine derivatives
GB9900334D0 (en) 1999-01-07 1999-02-24 Angiogene Pharm Ltd Tricylic vascular damaging agents
GB9900752D0 (en) 1999-01-15 1999-03-03 Angiogene Pharm Ltd Benzimidazole vascular damaging agents
EP1187615A2 (en) 1999-02-02 2002-03-20 K.U. Leuven Research & Development Immunosurpressive effects of pteridine derivatives
US6248755B1 (en) 1999-04-06 2001-06-19 Merck & Co., Inc. Pyrrolidine modulators of chemokine receptor activity
US6142484A (en) 1999-04-15 2000-11-07 Vassallo Research & Development Corporation Composite multi-pressure gasket
WO2000076514A1 (en) 1999-06-11 2000-12-21 Merck & Co., Inc. Cyclopentyl modulators of chemokine receptor activity
US6340681B1 (en) 1999-07-16 2002-01-22 Pfizer Inc 2-benzimidazolylamine compounds as ORL-1-receptor agonists
YU18502A (en) 1999-09-15 2004-12-31 Warner-Lambert Company Pteridinones as kinase inhibitors
SE9903544D0 (en) 1999-10-01 1999-10-01 Astra Pharma Prod Novel compounds
AR025884A1 (en) 1999-10-01 2002-12-18 Takeda Pharmaceutical CYCLINE AMINE COMPOUNDS, ITS PRODUCTION AND USE
EP1122257B1 (en) 2000-01-05 2005-10-12 Pfizer Inc. Benzimidazole compounds as ORL1-receptor agonists
JP2003522191A (en) 2000-02-11 2003-07-22 アストラゼネカ・アクチエボラーグ Pyrimidine compounds and their use as modulators of chemokine receptor activity
GB2359079A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359078A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
GB2359081A (en) 2000-02-11 2001-08-15 Astrazeneca Uk Ltd Pharmaceutically active thiazolopyrimidines
GB2359551A (en) 2000-02-23 2001-08-29 Astrazeneca Uk Ltd Pharmaceutically active pyrimidine derivatives
EP1277737A4 (en) 2000-03-24 2003-05-07 Meiji Seika Kaisha Diphenylalkylamine derivatives useful as opioid delta receptor agonists
WO2001092224A1 (en) 2000-05-31 2001-12-06 Astrazeneca Ab Indole derivatives with vascular damaging activity
MXPA02012905A (en) 2000-07-07 2004-07-30 Angiogene Pharm Ltd Colchinol derivatives as vascular damaging agents.
CZ200331A3 (en) 2000-07-07 2003-04-16 Angiogene Pharmaceuticals Limited Colchinol derivatives functioning as angiogenesis inhibitors, process of their preparation and pharmaceutical composition in which the derivatives are comprised
SE0101322D0 (en) 2001-04-12 2001-04-12 Astrazeneca Ab Novel compounds
SE0102716D0 (en) 2001-08-14 2001-08-14 Astrazeneca Ab Novel compounds
GB0221828D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound
GB0221829D0 (en) 2002-09-20 2002-10-30 Astrazeneca Ab Novel compound

Also Published As

Publication number Publication date
ES2276836T3 (en) 2007-07-01
DE60125801T2 (en) 2007-10-11
WO2002032507A1 (en) 2002-04-25
ATE350102T1 (en) 2007-01-15
SE0003828D0 (en) 2000-10-20
US7071193B2 (en) 2006-07-04
EP1328319A1 (en) 2003-07-23
DE60125801D1 (en) 2007-02-15
JP2004511532A (en) 2004-04-15
JP4250416B2 (en) 2009-04-08
US20040102447A1 (en) 2004-05-27
EP1328319B1 (en) 2007-01-03

Similar Documents

Publication Publication Date Title
AU2001296151A1 (en) 7-amino-2-alkylthiopteridin-4-yl-amines for the treatment of chemokine-related diseases
HUP0400718A2 (en) Use of pde 7 and pde 4 dual inhibitors for the preparation of pharmaceutical compositions to treat leukocyte activation-associated disorders
EP1348709A3 (en) Thiazolo (4,5-D) pyrimidine compounds
CA2288375A1 (en) Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage
CN1353609B (en) Amide substituted imidazoquinolines
JP2005529890A5 (en)
NO20000573D0 (en) Chemical connections
EP0403158A3 (en) Imidazolyl-alkenoic acids
MXPA05008148A (en) Novel fused heteroaromatic compounds as transforming growth factor (tgf) inhibitors.
EP2338886A3 (en) Naphthalene derivatives
WO2003004480A3 (en) Substituted piperazine and diazepanes as histamine h3 receptor agonists
MXPA04002379A (en) Urea-compounds active as vanilloid receptor antagonists for the treatment of pain.
ATE330585T2 (en) TREATMENT OF RESPIRATORY DISEASES
RU2005141064A (en) SPECIFIC Glucocorticosteroid Compound with Anti-Inflammatory Activity
MY162623A (en) Immunoglobulin formulation and method of preparation thereof
EP1916254A3 (en) 17alpha-alkyl-17beta-oxy-estratriene and intermediates for its production, use of 17alpha-alkyl-17beta-oxy-estratriene for manufacturing medicine and pharmaceutical preparations
WO1999024076A3 (en) Salicylate derivatized therapeutic and diagnostic agents
ATE479433T1 (en) NEW LONG-ACTING BETA-2 AGONISTS AND THEIR USE AS MEDICINAL PRODUCTS
HUP0401268A2 (en) Pharmaceutical compositions comprising combinations of estrogen agonists/antagonists, estrogens and progestins and process for their preparation
IT1226727B (en) PRECURSOR DRUGS OF DOPAMIN.
BR0109294A (en) • Polysaccharide ester, pharmaceutical compositions, use of the polysaccharide ester, and, process for the preparation of polysaccharide esters
WO2002096467A3 (en) Pharmaceutical use for secreted bacterial effector proteins
WO2002004487A3 (en) Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
JPH01151528A (en) Transmucous absorbefacient
CA2269128A1 (en) Piperazino derivatives as neurokinin antagonists